Free Webinar on Autism with Dr. Tramontano of The NeuroCognitive & Behavioral Institute
Functional Brain Mapping and Neuromodulation: In the Treatment of Autism
Monday, May 20, 2019
Time: 10:00-11:15AM
Brain mapping using newer diagnostics such as fMRI and electrical neuroimaging allows us to view neurophysiological abnormalities such as cortical connectivity deviations in patients with Autism. Neuromodulation uses non-invasive techniques such as tDCS, tRNS and tACS to modulate these cortical network abnormalities in an attempt to remediate some of the cognitive, language and social pragmatics deficits in Autism.
Missed the live webinar?
Watch the recording at your convenience. Feel free to reach out to us if you have any questions.
Presenter: Gerald Tramontano, Ph.D., Medical Director
About Dr. Tramontano:
Dr. Gerald Tramontano conducts a variety of sponsored and investigator-initiated pharmacological, nutraceutical and neurodiagnostic research. As a Principal Investigator, Dr. Tramontano has completed approximately 70 clinical research studies. His clinical research experience in drug development ranges from bioavailabilty / bioequivalent studies, as well as, first in humans Phase I studies through Phase IV clinical trials. The majority of his clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease. He has authored several published neuroscience-related and pharmacology articles in medical and forensic journals. Read more about Dr. Tramontano.
Missed our previous webinar on Functional Brain Mapping and Neuromodulation: In the Treatment of Alzheimer’s Disease? You can watch the recording here.
